BioMed Research International

BioMed Research International / 2017 / Article

Research Article | Open Access

Volume 2017 |Article ID 2756891 |

Lu Liu, Rong Huang, Ruiqi Yang, Xi Wei, "OCT4B1 Regulates the Cellular Stress Response of Human Dental Pulp Cells with Inflammation", BioMed Research International, vol. 2017, Article ID 2756891, 10 pages, 2017.

OCT4B1 Regulates the Cellular Stress Response of Human Dental Pulp Cells with Inflammation

Academic Editor: Takashi Yazawa
Received08 Jan 2017
Revised11 Mar 2017
Accepted16 Mar 2017
Published04 Apr 2017


Introduction. Infection and apoptosis are combined triggers for inflammation in dental tissues. Octamer-binding transcription factor 4-B1 (OCT4B1), a novel spliced variant of OCT4 family, could respond to the cellular stress and possess antiapoptotic property. However, its specific role in dental pulpitis remains unknown. Methods. To investigate the effect of OCT4B1 on inflammation of dental pulp cells (DPCs), its expression in inflamed dental pulp tissues and DPCs was examined by in situ hybridization, real-time PCR, and FISH assay. OCT4B1 overexpressed DPCs model was established, confirmed by western blot and immunofluorescence staining, and then stimulated with Lipopolysaccharide (LPS). Apoptotic rate was determined by Hoechst/PI staining and FACS. Cell survival rate was calculated by CCK8 assay. Results. In situ hybridization, real-time PCR, and FISH assay revealed that OCT4B1 was extensively expressed in inflamed dental pulp tissues and DPCs with LPS stimulation. Western blot and immunofluorescence staining showed the expression of OCT4B1 and OCT4B increased after OCT4B1 transfection. Hoechst/PI staining and FACS demonstrated that less red/blue fluorescence was detected and apoptotic percentage decreased (3.45%) after transfection. CCK8 demonstrated that the survival rate of pCDH-OCT4B1-flag cells increased. Conclusions. OCT4B1 plays an essential role in inflammation and apoptosis of DPCs. OCT4B might operate synergistically with OCT4B1 to reduce apoptosis.

1. Introduction

The dental pulp tissue is surrounded by inelastic pulp chamber resulting in rapid tissue edema and necrosis in response to inflammation. Due to lacking of effective collateral circulation, bacteria induced dental pulpitis is difficult to reverse. Dental pulp cells (DPCs), a heterogeneous cell population, contain progenitor/stem cells with self-renewal, colony-forming efficiency, and multilineage differentiation capability. DPCs are able to differentiate into odontoblasts, chondrocytes, adipocytes, neurons, and so forth. DPCs are hopeful cell source for dental tissue regeneration [1, 2].

Considerable evidence shows that the suboptimal regenerative outcomes are associated with infections and necrosis mediated by inflammatory responses [3]. For bone regeneration, a mild immune response is necessary in the early stage of regeneration to initiate the healing cascade. If the immune response stays mild and is resolved promptly, tissue regeneration occurs. Nevertheless, once healing tissues become infected and the inflammatory response persists, an adverse effect on bone regeneration occurs [47]. Correspondingly, dental pulp exposed to bacteria may become inflamed and irritated by Lipopolysaccharide (LPS). Exposure to LPS activates the cellular stress response, which results in apoptosis and cell death in dental pulp. Pathological alternations of DPCs caused by LPS could give rise to acute dental pain and adversely affect the repair process [810]. Therefore, it is of great importance to develop the anti-inflammatory strategy during dental regeneration.

Octamer-binding transcription factor 4 (OCT4, OTF3, and OTF4), belonging to the POU (Pit-Oct-Unc) family, consists of numerous transcription factors owning the same POU domain. Most of the transcription factors take part in early embryogenesis and exert the regulation property in lineage specific differentiation and neural development [11]. Like other members, OCT4 has different connecting regions and two conservative subdomains, which can interact with DNA to activate or inhibit the expression of target genes [12]. Human OCT4 gene locates on chromosome 6 and contains 5 exons [13]. It consists of three splicing variants, termed OCT4A (variant 1, NM_002701), OCT4B (variant 2, NM_203289), and OCT4B1 (variant 3, EU518650). OCT4B1 is mainly expressed in pluripotent cells, albeit being barely expressed in differentiated cells, indicating that it might be an essential marker for stem cells [14, 15]. It also contributes to tumorigenesis of gastric cancer and colorectal cancer [16, 17]. More importantly, OCT4B1 was able to encode the same protein isoforms of OCT4B since OCT4B1 mRNA could be spliced into OCT4B mRNA during transcription. The splicing can be inhibited by the mutation of the classical splicing site from OCT4B1, suggesting that OCT4B may originate from OCT4B1 during mRNA alternative splicing [18]. So far, the relationship between OCT4B1 and OCT4B, as well as their roles in inflammation, remains unknown. Therefore, the present study is to identify the effect of Oct4B1 on the antiapoptotic performance of DPCs in response to inflammation, in order to elucidate the relationship between dental inflammation and regeneration.

It is reported that OCT4B1 plays an antiapoptotic role in cancer cells, which might be associated with cellular stress [16, 19, 20]. Our previous studies revealed that OCT4 was expressed in the early passages of DPCs and its expression decreased during cell differentiation [21]. We also demonstrated that OCT4 expression was upregulated three times under the ischemia condition in vitro [22]. Here we extended our investigation to the effect of the splicing variant OCT4B1 on the antiapoptotic property of DPCs in response to inflammation, in order to elucidate the relationship between inflammation and regeneration.

2. Materials and Methods

2.1. Tissue Preparation and Cell Culture of DPCs

Extracted wisdom teeth including those diagnosed as irreversible pulpitis were collected after obtaining informed consent from every patient (18–25 years old). Ethics approval for this study was granted by the Ethics Committee of Sun Yat-Sen University. The teeth were split along the developmental groove and fixed with 4% paraformaldehyde for 24 h. They were then decalcified, embedded in paraffin, and prepared into 4 mm thick serial sections. All the surgical instruments and glass slides used for RNA detection were treated with diethylpyrocarbonate (DEPC, Beyotime, Guangzhou, China) to inactivate RNase enzymes. DPCs were cultured as previously described [23]. Briefly, DPCs were cultured in Dulbecco’s modified Eagle medium with low glucose (DMEM-LG, Invitrogen, CA, USA) supplemented with 10% fetal bovine serum (FBS, HyClone, UT, US), 10 U/mL penicillin, and 10 μg/mL streptomycin (Invitrogen, CA, USA), and incubated at 37°C in 5% CO2. The medium was changed every 3 days. The cells were passaged using 0.25% trypsin/EDTA (Life Technologies, Carlsbad, California, USA).

2.2. In Situ Hybridization

The digoxin and fluorescent probes (Biosense, Guangzhou, China) were synthesized with the following sequence: 5′-CCATTCGGGATTCAAGAACCTAC-3′. 6-Carboxyfluorescein (6-FAM) was labeled at the 3′ terminal for the latter. Paraffin sections were first stained with hematoxylin-eosin (HE) and divided into two groups according to the pathological changes. All the sections were dewaxed, dehydrated, and digested by pepsin at 37°C for 30 min. After 2 h before hybridization, dental pulp tissues were hybridized with the digoxin probe at 37°C overnight. Biotin-labeled digoxin antibody, streptavidin–biotin–peroxidase complex (SABC), and biotinylated peroxidase were added dropwise. Sections were developed with DAB and hematoxylin and then mounted with neutral gum.

2.3. Expression of OCT4B1 in DPCs with LPS Treatment

For OCT4B1 detection, DPCs were seeded in a 6-well plate with 5 × 105 cells/well. After 24 h incubation, the culture medium was removed and cells were stimulated with 100 ng/mL LPS derived from Escherichia coli 0111:B4 (Sigma, Missouri, USA) as previously described [7]. DPCs were then fixed for 20 min and permeabilized with 0.5% Triton X-100 for another 15 min. After ethanol dehydration and probe degeneration, hybridization buffer mixed with the probe was added and hybridized overnight at 37°C. After being washed with 50% formamide and 2x Standard Saline Citrate (SSC), the cells were counterstained with DAPI (1 : 1400) and observed under confocal laser scanning microscopy (Carl Zeiss, Germany).

DPCs were stimulated with 100 ng/m LPS for 24, 48, and 72 h, respectively. Total RNA was extracted by TRIzol reagent (Life Technologies, CA, USA) for mRNA detection. One microgram of total RNA was used for reverse transcription into cDNA (Transcription First Strand cDNA Synthesis Kit, Roche, Rotkreuz, Switzerland) and twenty microliter was used for PCR amplification (SYBR Green I Master, Roche, Switzerland). The primers in this experiment were listed as follows: OCT4B1 (forward: 5′-GGGTTCTATTTGGTGGGTTCC-3′, reverse: 5′-TCCCTCTCCCTACTCCTCTTCA-3′); β-actin (forward: 5′-AGTGGGTTGTTTGCCTTTGG-3′; reverse: 5′-TCGTCCCAGTTGGTGACGAT-3′). The whole process of amplification was 40 cycles and repeated denaturing at 95°C, annealing at 55°C, and extension at 72°C. The data were analyzed by method.

2.4. Lentiviral Transfection of OCT4B1 in DPCs and Western Blot

Since there is no specific antibody for OCT4 isoform OCT4B1, we designed, produced, and characterized OCT4B1 with a FLAG tag embedded upstream of the RGD motif. Briefly, OCT4B1 was amplified by PCR and cloned into pCDH-CMV-MCS-EF1-GFP and pCDH-CMV-MCS-EF1-puro lentiviral vector (Dakai Biotech. Co., Guangzhou, China). The flag octa peptide was bound to the plasmid for the sake of generating fusion protein of OCT4B1, psPAX, and pMD2. Lentivirus packaging system and the plasmid were used to transfect 293T cells. After 48 h incubation, the supernatant was harvested and lentivirus titer was obtained. The virus liquid was then used to infect DPCs. The optimal multiplicity of infection (MOI) was determined. The recombinants generated with OCT4B1, flag, or GFP genes were termed pCDH-OCT4B1-flag-GFP, pCDH-GFP, pCDH-OCT4B1-flag, and pCDH, respectively. The nontransfected DPCs served as control.

DPCs were harvested with sodium dodecyl sulfate (SDS) lysis buffer, sonicated, and centrifuged at 12,000 for 10 minutes. The total protein in cell extract was measured by Pierce BCA Protein Assay Kit (Thermo Scientific, USA). Twenty micrograms of protein was separated by sodium dodecyl sulfate-polyacrylamide gel electrophoresis (SDS-PAGE) and transferred to a nitrocellulose membrane using 200 mA for 1 h. The nitrocellulose membrane was blocked in 5% nonfat milk for 1 h at room temperature, rinsed, and incubated with anti-OCT4B antibody (1 : 1000, Bioss, MA, USA) and anti-tag antibodies (DDK antibodies) (1 : 4000, Origene, MD, USA) overnight at 4°C. After washing three times, the membrane was incubated with the donkey anti-goat IgG-HRP and goat anti-mouse IgG-HRP (1 : 4000, Santa Cruz, CA, USA) at room temperature for 1 hour. Novex ECL Chemiluminescent Substrate Reagent Kit (Life Technologies, CA, USA) was used to collect the luminescent signals.

2.5. Immunofluorescence Staining of FLAG Tag in DPCs

DPCs were seeded and fixed on cell slides. All the slides were blocked in 3% BSA for 30 minutes at room temperature. Mouse monoclonal anti-DDK antibody (1 : 4000, Origene, MD, USA) was used for detection of flag tag. Alexa Fluor® 647 conjugated anti-mouse IgG fragments (1 : 1000, Cell Signaling Technology, MA, USA) staining was performed for 1 h at room temperature. The stained cells were observed under the confocal laser scanning microscopy (Carl Zeiss, Germany).

2.6. Apoptosis and Necrosis Analysis

DPCs were cultured in 24-well plates and stimulated with 100 ng/mL LPS for 24 h. The cells were stained with Hoechst 33342/PI Double Staining Kit (Keygen Biotech Co., Nanjing, China) for 10 min at room temperature and observed under the inverted fluorescence microscope. For fluorescence activated cell sorting (FACS) analysis, cells were digested with EDTA-free trypsin and stained with Hoechst 33342/PI at room temperature for 10 minutes. Blue fluorescent of Hoechst 33342 and red fluorescence of PI were captured with Gallios Flow Cytometer (Beckman coulter, CA, USA).

2.7. Cell Viability Analysis

DPCs were seeded in 6-well plates and starved in serum-free medium overnight. The result of LPS cytotoxicity was examined by Cell Counting Kit-8 (CCK-8, Jingxin, Guangzhou, China). The optical density (OD) value was assayed to calculate the final cell number. Cell survival rate was calculated as follows: cell viability (%) = (cell number (LPS) − cell number (blank))/(cell number (without LPS) − cell number (blank)) × 100.

2.8. Statistical Analysis

All experiments were repeated at least three times. The SPSS19.0 software package (SPSS Inc., Chicago, IL) was used for the statistical tests. All the data were analyzed using one-way ANOVA analysis and Student’s -test. The difference was considered as being of statistical significance at .

3. Results

3.1. OCT4B1 Expression in Dental Pulp with Inflammation

The structure and pathological states of dental pulp tissues were detected by HE staining. Odontoblasts lined along the pulp-dentin border below which the tubular dentin was regularly presented in noninflamed dental pulp (Figure 1(a)). In inflamed dental pulp tissues, odontoblasts were surrounded by locally infiltrated immune cells and disorganized tubular dentin was observed beneath the odontoblasts layer (Figure 1(b)). In situ hybridization assay revealed that, in the noninflamed dental pulp tissues, OCT4B1 was weakly expressed in normal DPCs (Figures 1(c) and 1(e), ×200 and  ×400), whereas OCT4B1 was extensively expressed in both the cytoplasm and nucleus of the inflamed DPCs (Figures 1(d) and 1(f), ×200 and  ×400).

3.2. Expression of OCT4B1 in DPCs with LPS Treatment

The result of real-time PCR revealed that OCT4B1 mRNA expression in DPCs increased significantly over time () (Figure 2(a)). FISH assay showed that punctiform green fluorescence was weakly expressed in the cytoplasm of normal DPCs (Figure 2(b), B1–B3), whereas the green fluorescence was enhanced and gathered in the cytoplasm around nucleus of DPCs after 72 h LPS stimulation (Figure 2(b), B4–B6). Both of the results indicated the correlation between OCT4B1 and LPS-induced inflammation.

3.3. Expression of OCT4B1 in DPCs after Lentiviral Transfection

Green fluorescence was observed in the nucleus and cytoplasm of both pCDH-OCT4B1-flag (Figure 3(c), C2) and pCDH-flag cells (Figure 3(b), B2). Red fluorescence representing flag octa peptide was expressed only in the nucleus and cytoplasm of pCDH-OCT4B1-flag-GFP cells (Figure 3(c), C3), indicating the successful induced expression of OCT4B1 in DPCs after transfection. Neither green nor red fluorescence was expressed in nontransfected cells (Figure 3(a), A2–A4). The results of western blot agreed with the above results; no protein band was detected in nontransfected pCDH-GFP cells. 23 KD (OCT4B1) and 33 KD (OCT4B) protein bands were detected with OCT4B1 flag antibody (Figure 3(d)). There was a blurred band of 33 KD detected with OCT4B antibody, demonstrating that the expression of OCT4B was increased after OCT4B1 transfection (Figure 3(e)).

3.4. Effect of OCT4B1 in DPCs with LPS Induction

Plasmids without GFP were used to avoid spectral cross of green fluorescence in this experiment. Cells with or without lentiviral transfection were stimulated with 100 ng/mL LPS for 24 h. Hoechst/PI staining showed less red fluorescence and blue fluorescence was detected in DPCs with OCT4B1 overexpression (Figure 4(a), A8) compared with nontransfected (Figure 4(a), A2) and pCDH DPCs (Figure 4(a), A5). The results of FACS showed the percentage of apoptotic cells was decreased (3.45%) in DPCs with OCT4B1 overexpression compared with the nontransfected and pCDH DPCs (10.41% and 10.06%) (Figure 4(b)). The line graph showed the survival rate of pCDH-OCT4B1-flag cells was significantly higher than nontransfected and pCDH DPCs () (Figure 4(c)).

4. Discussion

OCT4 is a crucial stemness marker expressed in embryonic stem cells (ESCs) and embryonic carcinoma cells (ECCs). In 2006, Takahashi and Yamanaka generated the induced pluripotent stem (iPS) cells from fibroblasts by introducing four factors, OCT4, Sox2, c-Myc, and Klf4 [24]. The follow-up study confirmed that a single factor OCT4 could induce the generation of iPS cells [25]. The inner cell mass was not able to maintain the pluripotency in OCT4 gene knockout mice [26], which highlighted the important role of OCT4 in cell reprogramming. Study revealed that knocking out OCT4 with Cre/Loxp system in primordial germ cells (PGCs) led to apoptosis of PGCs rather than differentiation into trophectodermal lineages [27], providing the evidence of the functional diversity of OCT4.

The discovery of OCT4B1 ignited the hot investigation into OCT4 family. The initial study of OCT4B1 demonstrated that it was extensively expressed in human ESCs and ECCs and downregulated during differentiation [14]. It was also expressed in nonpluripotent cells such as gastric adenocarcinoma, bladder tumor, and colorectal cancer cells, as well as normal adult stem cells [16, 17, 20]. OCT4B1 expression in bladder cancer cells increased when heated up at 45°C [18]. Interfering with OCT4B1 siRNA, the morphology and cell cycle of gastric adenocarcinoma cells (AGS) were altered remarkably, suggesting the potential functional change of AGS [19]. Suppression of OCT4B1 in several tumorous cell lines resulted in upregulation of proapoptotic genes and downregulation of antiapoptotic genes, which implies that OCT4B1 might affect apoptotic rate through several stress related pathways [28]. Therefore, OCT4B1 may play an important role in the regulation of cellular stress. Moreover, OCT4B1 expression levels were elevated in both tissue and blood samples from patients with inflammatory bowel disease as a result of tissue damage, indicating a possible role of OCT4B1 played in anti-inflammation and regeneration [29]. In the present study, the ISH and FISH assay indicated that OCT4B1 expression was elevated in the inflamed dental pulp and in DPCs with LPS induction, suggesting that OCT4B1 might be involved in the cellular stress.

OCT4 is a transcriptional factor functioning in nucleus. However, the splicing variant OCT4B1 was reported to be expressed in the cytoplasm of cancer cells [19]. Our previous data showed that the activity of OCT4 in PDLCs was associated with pluripotency and multilineage differentiation potential, which might be controlled by nucleus-cytoplasmic shuttling [30]. In the present study, we found that OCT4B1 was mainly located in the cytoplasm around nucleus of DPCs after LPS treatment, implying the potential nucleus-cytoplasm shuttling of OCT4B1 in inflamed DPCs, whereas OCT4B1 fusion protein was expressed in both nucleus and cytoplasm of DPCs after transfection. These results may be contributed to the complicated roles of OCT4, since initiation of translation usually generates functional diversity through regulation of the localization of protein isoforms. When the cytoplasmic location is detected, the nuclear envelope is disassembled, allowing proteins swap between nucleus and cytoplasmic compartments [30]. It might be possible that OCT4B1 was firstly located in nucleus, then translocated into cytoplasm, and functioned as an inflammation regulator. Thus the translocation of OCT4B1 from the nucleus to the cytoplasm may reflect its potential alternation of cell characteristics in response to inflammation.

OCT4A is highly concentrated in the nucleus of cells during human preimplantation development. Compared with OCT4A, OCT4B encodes a diverse N-terminal domain (NTD) at the start of the protein, localized mainly in the cytoplasm of most nonpluripotent cells and somatic cells [31, 32]. The electromobility shift assay revealed that the N-terminal domain (NTD) of OCT4B inhibits the binding of OCT4 to the DNA and prevents activation of transcription related genes. Therefore, OCT4B cannot sustain the pluripotency and self-renewal of ES (embryonic stem) cells and overexpression of OCT4B cannot activate transcription from OCT4-dependent promoters [33]. Researchers used different primer sets for OCT4B isoform and found that ES and EC cells consistently expressed another variant of OCT4, named OCT4B1. OCT4B1 is highly expressed in ESCs and ECCs (embryonic carcinoma cells) and is rapidly downregulated upon induction of differentiation. Based on their study on stage specific embryonic antigen 3 positive (SSEA3+) stem cells, there is a potential relationship between the expression of OCT4B1 and the undifferentiated state of ES cells [30]. However, so far no evidence shows the localization alternation of OCT4B1 and its potential correlation with OCT4A and OCT4B. Thus in the present study, we examined the expression of OCT4B after OCT4B1 lentiviral transfection. Expression of OCT4B was elevated along with upregulation of OCT4B1. The results showed that OCT4B1 might encode OCT4B. This can be conceived as there was an overlap in the translation process of OCT4B1 and OCT4B. It is possible that a certain amount of OCT4B1 mRNA was alternatively spliced into OCT4B mRNA after lentiviral transfection. This is in accord with the report of OCT4B1 in tumor cell lines [18]. Therefore, we provided the evidence that OCT4B1 might be the precursor of OCT4B.

It is reported that the apoptotic rate of Hela cells with OCT4B overexpression was downregulated after being induced at 45°C for 2 h, suggesting that OCT4B had an antiapoptotic property in response to cellular stress [34]. However, whether this function was associated with OCT4B1 remains unknown. It is also demonstrated that downregulation of OCT4B1 could enhance the activity of caspase-3 and caspase-7 in AGS and the number of apoptotic cells significantly increased compared with the nontreated cells [16]. In our study, the cell viability was remarkably upregulated in DPCs with OCT4B1 overexpression under inflammatory conditions. This is probably because OCT4B1 exert an antiapoptotic effect on DPCs and may be attributed to the maintenance of cell survival. Moreover, OCT4B1 may convert into OCT4B to perform the antiapoptotic function.

So far, there is no specific antibody for OCT4 isoform OCT4B1, which makes it difficult for researchers to study the distinct potential roles of OCT4 isoforms in regeneration and inflammation. In the present study, we designed, produced, and characterized OCT4B1 with a FLAG tag embedded upstream of the RGD motif. Moreover, the embedded FLAG tag was recognized by anti-FLAG (DDK) antibodies, which allowed OCT4B1-FLAG to be distinguished by western blot assay. Epitope tags encoded in DNA sequences provide a way to localize genes in various cell types and characterize newly identified, low abundance, or poorly immunogenic proteins without specific antibodies. The commercially available antibodies to epitope tags (DDK antibodies) are developed to optimize the detection and purification of the recombinant proteins. DDK antibodies with high sensitivity and specificity are commercially produced and widely used in various literatures. Thus epitope tags are an attractive approach to proteins without further requirement of generation and validation of protein-specific antibodies [35, 36]. Therefore, the knowledge generated from the present study might shed light on the methodology to explore the potential roles of OCT4 isoforms in the future study.

Taken together, the present study revealed that OCT4B1 is closely related to the inflamed dental pulp and possesses an antiapoptotic property through regulation of OCT4B. OCT4B1 might be one of the antiapoptotic candidates for pulpitis. However, further studies are needed to investigate the underlying mechanism of OCT4B1 in apoptosis and its potential role in dental regeneration.

Conflicts of Interest

The authors deny any conflicts of interest related to this study.

Authors’ Contributions

Lu Liu and Rong Huang contributed equally as first coauthors to this study.


This study was supported by National Natural Science Foundation of China (81670983/81400499) and Guangdong Provincial Department of Science and Technology (2015A020212004).


  1. D. Tziafas, A. J. Smith, and H. Lesot, “Designing new treatment strategies in vital pulp therapy,” Journal of Dentistry, vol. 28, no. 2, pp. 77–92, 2000. View at: Publisher Site | Google Scholar
  2. N. Tamaoki, K. Takahashi, T. Tanaka et al., “Dental pulp cells for induced pluripotent stem cell banking,” Journal of Dental Research, vol. 89, no. 8, pp. 773–778, 2010. View at: Publisher Site | Google Scholar
  3. X. Wei, J. Ling, L. Wu, L. Liu, and Y. Xiao, “Expression of mineralization markers in dental pulp cells,” Journal of Endodontics, vol. 33, no. 6, pp. 703–708, 2007. View at: Publisher Site | Google Scholar
  4. M. V. Thomas and D. A. Puleo, “Infection, inflammation, and bone regeneration: a paradoxical relationship,” Journal of Dental Research, vol. 90, no. 9, pp. 1052–1061, 2011. View at: Publisher Site | Google Scholar
  5. R. C. Jacinto, B. P. F. A. Gomes, H. N. Shah, C. C. Ferraz, A. A. Zaia, and F. J. Souza-Filho, “Quantification of endotoxins in necrotic root canals from symptomatic and asymptomatic teeth,” Journal of Medical Microbiology, vol. 54, no. 8, pp. 777–783, 2005. View at: Publisher Site | Google Scholar
  6. C. Kitamura, T. Nishihara, Y. Ueno et al., “Effects of sequential exposure to lipopolysaccharide and heat stress on dental pulp cells,” Journal of Cellular Biochemistry, vol. 99, no. 3, pp. 797–806, 2006. View at: Publisher Site | Google Scholar
  7. H. Yang, Y. T. Zhu, R. Cheng et al., “Lipopolysaccharide-induced dental pulp cell apoptosis and the expression of Bax and Bcl-2 in vitro,” Brazilian Journal of Medical and Biological Research, vol. 43, no. 11, pp. 1027–1033, 2010. View at: Publisher Site | Google Scholar
  8. S. J. Fokkema, “Peripheral blood monocyte responses in periodontitis,” International Journal of Dental Hygiene, vol. 10, no. 3, pp. 229–235, 2012. View at: Publisher Site | Google Scholar
  9. J. Geng, S. Xiao, Z. Zheng, S. Song, and L. Zhang, “Gambogic acid protects from endotoxin shock by suppressing pro-inflammatory factors in vivo and in vitro,” Inflammation Research, vol. 62, no. 2, pp. 165–172, 2013. View at: Publisher Site | Google Scholar
  10. M. Yokoyama, T. Ukai, E. R. Ayon Haro, T. Kishimoto, Y. Yoshinaga, and Y. Hara, “Membrane-bound CD40 ligand on T cells from mice injected with lipopolysaccharide accelerates lipopolysaccharide-induced osteoclastogenesis,” Journal of Periodontal Research, vol. 46, no. 4, pp. 464–474, 2011. View at: Publisher Site | Google Scholar
  11. H. R. Schöler, S. Ruppert, N. Suzuki, K. Chowdhury, and P. Gruss, “New type of POU domain in germ line-specific protein Oct-4,” Nature, vol. 344, no. 6265, pp. 435–439, 1990. View at: Publisher Site | Google Scholar
  12. M. Pesce and H. R. Schöler, “Oct-4: control of totipotency and germline determination,” Molecular Reproduction and Development, vol. 55, no. 4, pp. 452–457, 2000. View at: Publisher Site | Google Scholar
  13. B. R. Krishnan, I. Jamry, and D. D. Chaplin, “Feature mapping of the HLA class I region: localization of the POU5F1 and TCF19 genes,” Genomics, vol. 30, no. 1, pp. 53–58, 1995. View at: Publisher Site | Google Scholar
  14. S. I. Papamichos, V. Kotoula, B. C. Tarlatzis, T. Agorastos, K. Papazisis, and A. F. Lambropoulos, “OCT4B1 isoform: the novel OCT4 alternative spliced variant as a putative marker of stemness,” Molecular Human Reproduction, vol. 15, no. 5, pp. 269–270, 2009. View at: Publisher Site | Google Scholar
  15. M. A. Rijlaarsdam, H. A. D. M. Van Herk, A. J. M. Gillis et al., “Specific detection of OCT3/4 isoform A/B/B1 expression in solid (germ cell) tumours and cell lines: confirmation of OCT3/4 specificity for germ cell tumours,” British Journal of Cancer, vol. 105, no. 6, pp. 854–863, 2011. View at: Publisher Site | Google Scholar
  16. M. H. Asadi, S. J. Mowla, F. Fathi, A. Aleyasin, J. Asadzadeh, and Y. Atlasi, “OCT4B1, a novel spliced variant of OCT4, is highly expressed in gastric cancer and acts as an antiapoptotic factor,” International Journal of Cancer, vol. 128, no. 11, pp. 2645–2652, 2011. View at: Publisher Site | Google Scholar
  17. M. Gazouli, M. G. Roubelakis, G. E. Theodoropoulos et al., “OCT4 spliced variant OCT4B1 is expressed in human colorectal cancer,” Molecular Carcinogenesis, vol. 51, no. 2, pp. 165–173, 2012. View at: Publisher Site | Google Scholar
  18. Y. Gao, X. Wang, J. Han et al., “The novel OCT4 spliced variant OCT4B1 can generate three protein isoforms by alternative splicing into OCT4B,” Journal of Genetics and Genomics, vol. 37, no. 7, pp. 461–465, 2010. View at: Publisher Site | Google Scholar
  19. E. Farashahi Yazd, M. R. Rafiee, M. Soleimani, M. Tavallaei, M. K. Salmani, and S. J. Mowla, “OCT4B1, a novel spliced variant of OCT4, generates a stable truncated protein with a potential role in stress response,” Cancer Letters, vol. 309, no. 2, pp. 170–175, 2011. View at: Publisher Site | Google Scholar
  20. J. Asadzadeh, M. H. Asadi, N. Shakhssalim et al., “A plausible anti-apoptotic role of up-regulated OCT4B1 in bladder tumors,” Urology Journal, vol. 9, no. 3, pp. 574–580, 2012. View at: Google Scholar
  21. L. Liu, X. Wei, J. Ling, L. Wu, and Y. Xiao, “Expression pattern of Oct-4, sox2, and c-Myc in the primary culture of human dental pulp derived cells,” Journal of Endodontics, vol. 37, no. 4, pp. 466–472, 2011. View at: Publisher Site | Google Scholar
  22. J. Wang, X. Wei, J. Ling, Y. Huang, Y. Huo, and Y. Zhou, “The presence of a side population and its marker ABCG2 in human deciduous dental pulp cells,” Biochemical and Biophysical Research Communications, vol. 400, no. 3, pp. 334–339, 2010. View at: Publisher Site | Google Scholar
  23. G. T.-J. Huang, W. Sonoyama, J. Chen, and S. H. Park, “In vitro characterization of human dental pulp cells: various isolation methods and culturing environments,” Cell and Tissue Research, vol. 324, no. 2, pp. 225–236, 2006. View at: Publisher Site | Google Scholar
  24. K. Takahashi and S. Yamanaka, “Induction of pluripotent stem cells from mouse embryonic and adult fibroblast cultures by defined factors,” Cell, vol. 126, no. 4, pp. 663–676, 2006. View at: Publisher Site | Google Scholar
  25. Y. Li, Q. Zhang, X. Yin et al., “Generation of iPSCs from mouse fibroblasts with a single gene, Oct4, and small molecules,” Cell Research, vol. 21, no. 1, pp. 196–204, 2011. View at: Publisher Site | Google Scholar
  26. J. Nichols, B. Zevnik, K. Anastassiadis et al., “Formation of pluripotent stem cells in the mammalian embryo depends on the POU transcription factor Oct4,” Cell, vol. 95, no. 3, pp. 379–391, 1998. View at: Publisher Site | Google Scholar
  27. J. Kehler, E. Tolkunova, B. Koschorz et al., “Oct4 is required for primordial germ cell survival,” EMBO Reports, vol. 5, no. 11, pp. 1078–1083, 2004. View at: Publisher Site | Google Scholar
  28. M. R. Mirzaei, A. Najafi, M. K. Arababadi, M. H. Asadi, and S. J. Mowla, “Altered expression of apoptotic genes in response to OCT4B1 suppression in human tumor cell lines,” Tumor Biology, vol. 35, no. 10, pp. 9999–10009, 2014. View at: Publisher Site | Google Scholar
  29. M. Maragkoudaki, A. Vaiopoulou, G. E. Theodoropoulos et al., “Specific detection of OCT4 isoforms in inflammatory bowel disease,” Gut Pathogens, vol. 7, article 25, 2015. View at: Publisher Site | Google Scholar
  30. L. Liu, X. Wei, R. Huang, J. Ling, L. Wu, and Y. Xiao, “Effect of bone morphogenetic protein-4 on the expression of Sox2, Oct-4, and c-Myc in human periodontal ligament cells during long-term culture,” Stem Cells and Development, vol. 22, no. 11, pp. 1670–1677, 2013. View at: Publisher Site | Google Scholar
  31. Y. Atlasi, S. J. Mowla, S. A. M. Ziaee, P. J. Gokhale, and P. W. Andrews, “OCT4 spliced variants are differentially expressed in human pluripotent and nonpluripotent cells,” STEM CELLS, vol. 26, no. 12, pp. 3068–3074, 2008. View at: Publisher Site | Google Scholar
  32. G. Cauffman, H. Van de Velde, I. Liebaers, and A. Van Steirteghem, “Oct-4 mRNA and protein expression during human preimplantation development,” Molecular Human Reproduction, vol. 11, no. 3, pp. 173–181, 2005. View at: Publisher Site | Google Scholar
  33. G. Cauffman, I. Liebaers, A. Van Steirteghem, and H. Van De Velde, “POU5F1 isoforms show different expression patterns in human embryonic stem cells and preimplantation embryos,” Stem Cells, vol. 24, no. 12, pp. 2685–2691, 2006. View at: Publisher Site | Google Scholar
  34. X. Wang, Y. Zhao, Z. Xiao et al., “Alternative translation of OCT4 by an internal ribosome entry site and its novel function in stress response,” Stem Cells, vol. 27, no. 6, pp. 1265–1275, 2009. View at: Publisher Site | Google Scholar
  35. M. R. Hunter, N. L. Grimsey, and M. Glass, “Sulfation of the FLAG epitope is affected by co-expression of G protein-coupled receptors in a mammalian cell model,” Scientific Reports, vol. 6, article 27316, 2016. View at: Publisher Site | Google Scholar
  36. A. Einhauer and A. Jungbauer, “The FLAG™ peptide, a versatile fusion tag for the purification of recombinant proteins,” Journal of Biochemical and Biophysical Methods, vol. 49, no. 1–3, pp. 455–465, 2001. View at: Publisher Site | Google Scholar

Copyright © 2017 Lu Liu et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

More related articles

 PDF Download Citation Citation
 Download other formatsMore
 Order printed copiesOrder

Related articles

Article of the Year Award: Outstanding research contributions of 2020, as selected by our Chief Editors. Read the winning articles.